000 | 01069 a2200325 4500 | ||
---|---|---|---|
005 | 20250516020112.0 | ||
264 | 0 | _c20110131 | |
008 | 201101s 0 0 eng d | ||
022 | _a1527-9995 | ||
024 | 7 |
_a10.1016/j.urology.2010.05.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Donnell, Peter H | |
245 | 0 | 0 |
_aEditorial comment. _h[electronic resource] |
260 |
_bUrology _cJan 2011 |
||
300 |
_a165-6 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 |
_aCystectomy _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xphysiopathology |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPerioperative Care |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
700 | 1 | _aPosadas, Edwin M | |
773 | 0 |
_tUrology _gvol. 77 _gno. 1 _gp. 165-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urology.2010.05.008 _zAvailable from publisher's website |
999 |
_c20482221 _d20482221 |